Company intelligence
Hansa Biopharma
We are dedicated to bring innovative treatments to people living with rare immunological diseases.
Biotechnology Research
Lund, SE
148 employees
Founded 2007
1 public signals
About Hansa Biopharma
Hansa Biopharma, is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative and life altering treatments for patients with rare immunological conditions. Hansa scientists are working on developing immunomodulatory treatments for organ transplants, rare IgG-mediated autoimmune conditions, and gene therapy, as well as exploring the potential application of the technology platform in oncology.
Verified activity
Signals from Hansa Biopharma
1 published signal